+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 80Years
MALE
ID06992232

Phase II Study of Radiotherapy or Radical Prostatectomy with Intense Androgen Deprivation Therapy for Newly Diagnosed Metastatic Prostate Cancer in Men

Led by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated on 2025-05-28

144

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of combining radiotherapy or radical prostatectomy with intense androgen deprivation therapy for men newly diagnosed with metastatic prostate cancer. This phase II randomized controlled trial is conducted across multiple hospitals in China to better understand treatment outcomes for this condition. Participants receive intense androgen deprivation therapy, which includes androgen deprivation therapy plus second-generation androgen receptor inhibitors such as enzalutamide, apalutamide, darolutamide, or rezvilutamide for two years. In the experimental group, patients receive local treatment in addition to this systemic therapy. Local treatment can be either radiotherapy, delivered in specific doses over several sessions to the primary tumor and metastatic sites, or robot-assisted laparoscopic radical prostatectomy with extended pelvic lymph node dissection. All local treatments are completed within the two-year systemic therapy period. During the study, participants are closely monitored through various evaluations to measure outcomes such as event-free survival at two years, progression-free survival, time to castration-resistant prostate cancer, and adverse events over four years. The trial involves regular assessments including physical condition scoring and laboratory tests to ensure safety and track disease progression. Total participation may last several years to capture long-term results and treatment effects.

CONDITIONS

Brief Title

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

Research Team

J

Junlong Zhuang, PhD

H

Hongqian Guo, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here